Victoria Julian assists the firm in biotechnology patent prosecution. She has extensive knowledge in the areas of neuroscience, neurodegeneration, and axon regeneration. She also has considerable experience in genetics and genome editing. Victoria’s experience in patent prosecution includes contributing to the writing of patent applications, patentability, and landscape assessments.
Prior to joining Wolf Greenfield, Victoria earned her PhD from the University of Massachusetts Medical School. Victoria’s doctoral research focused on identifying genetic regulators of axon regeneration and degeneration in Caenorhabditis elegans. Victoria also worked as a compliance specialist at the Belfer Office for Dana-Farber Innovations (BODFI) of the Dana-Farber Cancer Institute, where she gained experience in technology transfer and federal compliance in research institutions.
- Award for Outstanding Mentoring in the Classroom or Research Setting, University of Massachusetts Medical School
- University Honors College Debate Scholar, University of Pittsburgh
- Julian, V., and Byrne A. tir-1/Sarm1 inhibits axon regeneration. bioRx (2020).
- Loring, H.S., Julian, V.L., Isco, J.I., O’Connor L., Parelkar, S.S., Byrne, A.B., and Thompson, P.R. A phase transition enhances the catalytic activity of SARM1, an NAD+ glycohydrolase involved in neurodegeneration. eLife (2021).
- Caneo, M., Julian, V., Byrne, A.B., Alkema, M.J., and Calixto, A. Diapause induces functional axonal regeneration after necrotic insult in C. elegans. PLoS Genetics (2019).
- Girouard, M.P., Bueno, M., Julian, V., Drake, S., Byrne, A.B., and Fournier, A.E. The Molecular Interplay between Axon Degeneration and Regeneration. Developmental Neurobiology (2018). Review.
Victoria enjoys traveling and running and recently completed the London Marathon.